mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.5 |
mRNA |
NU-7441 |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
0.037 |
0.5 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.5 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
SB 216763 |
GDSC1000 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.024 |
0.5 |